tirzepatide compound lawsuit Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute Troubling Findings in Study of

Becoming active can also be a major change for some individuals, making the idea of weight loss potentially unachievable

Use of GLP-1 receptor agonists was associated with a twofold higher risk for neovascular age-related macular degeneration development in a population-based study published in JAMA Ophthalmology

Artificial intelligence (AI) is hitting its stride in R&D

Specifically, Ozempic is approved by the Food and Drug Administration (FDA) for use to: help manage blood sugar levels in adults with type 2 diabetes, along with lifestyle improvements in diet and exercise lower the risk of certain heart or blood vessel problems including heart attack and stroke in adults who have both heart disease and diabetes lower the risk of kidney disease progression and heart-related death in adults with diabetes and chronic kidney disease (CKD)